These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30694931)

  • 1. The serum protease network-one key to understand complex regional pain syndrome pathophysiology.
    König S; Bayer M; Dimova V; Herrnberger M; Escolano-Lozano F; Bednarik J; Vlckova E; Rittner H; Schlereth T; Birklein F
    Pain; 2019 Jun; 160(6):1402-1409. PubMed ID: 30694931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced serum protease activity in Complex Regional Pain Syndrome: The impact of angiotensin-converting enzyme and carboxypeptidases.
    König S; Steinebrey N; Herrnberger M; Escolano-Lozano F; Schlereth T; Rebhorn C; Birklein F
    J Pharm Biomed Anal; 2021 Oct; 205():114307. PubMed ID: 34392129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P Serum Degradation in Complex Regional Pain Syndrome - Another Piece of the Puzzle?
    König S; Engl C; Bayer M; Escolano-Lozano F; Rittner H; Rebhorn C; Birklein F
    J Pain; 2022 Mar; 23(3):501-507. PubMed ID: 34678467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months.
    Lenz M; Üçeyler N; Frettlöh J; Höffken O; Krumova EK; Lissek S; Reinersmann A; Sommer C; Stude P; Waaga-Gasser AM; Tegenthoff M; Maier C
    Pain; 2013 Oct; 154(10):2142-2149. PubMed ID: 23811041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I) - longitudinal investigations and differences to control groups.
    Schinkel C; Scherens A; Köller M; Roellecke G; Muhr G; Maier C
    Eur J Med Res; 2009 Mar; 14(3):130-5. PubMed ID: 19380284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative Outcomes of Spinal Cord Stimulator Placement in Patients with Complex Regional Pain Syndrome Compared with Patients without Complex Regional Pain Syndrome.
    Martini ML; Caridi JM; Zeldin L; Neifert SN; Nistal DA; Kim JD; Khelemsky Y; Gal JS
    World Neurosurg; 2020 May; 137():e106-e117. PubMed ID: 31954908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological findings in complex regional pain syndromes--analysis of 145 cases.
    Birklein F; Riedl B; Sieweke N; Weber M; Neundörfer B
    Acta Neurol Scand; 2000 Apr; 101(4):262-9. PubMed ID: 10770524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared to limb pain of other origin, ultrasonographic osteodensitometry reveals loss of bone density in complex regional pain syndrome.
    Bazika-Gerasch B; Maier C; Kumowski N; Fiege C; Kaisler M; Vollert J; Dietrich JW
    Pain; 2019 Jun; 160(6):1261-1269. PubMed ID: 30747906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation in CRPS: role of the sympathetic supply.
    Schlereth T; Drummond PD; Birklein F
    Auton Neurosci; 2014 May; 182():102-7. PubMed ID: 24411269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is normal trauma healing and what is complex regional pain syndrome I? An analysis of clinical and experimental biomarkers.
    Dietz C; Müller M; Reinhold AK; Karch L; Schwab B; Forer L; Vlckova E; Brede EM; Jakubietz R; Üçeyler N; Meffert R; Bednarik J; Kress M; Sommer C; Dimova V; Birklein F; Rittner HL
    Pain; 2019 Oct; 160(10):2278-2289. PubMed ID: 31095096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The important role of neuropeptides in complex regional pain syndrome.
    Birklein F; Schmelz M; Schifter S; Weber M
    Neurology; 2001 Dec; 57(12):2179-84. PubMed ID: 11756594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IASP diagnostic criteria for complex regional pain syndrome: a preliminary empirical validation study. International Association for the Study of Pain.
    Galer BS; Bruehl S; Harden RN
    Clin J Pain; 1998 Mar; 14(1):48-54. PubMed ID: 9535313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and Systemic Expression Pattern of MMP-2 and MMP-9 in Complex Regional Pain Syndrome.
    Escolano-Lozano F; Gries E; Schlereth T; Dimova V; Baka P; Vlckova E; König S; Birklein F
    J Pain; 2021 Oct; 22(10):1294-1302. PubMed ID: 33892152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphic locus in the intron 16 of the human angiotensin-converting enzyme (ACE) gene is not correlated with complex regional pain syndrome I (CRPS I).
    Hühne K; Leis S; Schmelz M; Rautenstrauss B; Birklein F
    Eur J Pain; 2004 Jun; 8(3):221-5. PubMed ID: 15109972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin temperature side differences--a diagnostic tool for CRPS?
    Wasner G; Schattschneider J; Baron R
    Pain; 2002 Jul; 98(1-2):19-26. PubMed ID: 12098613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome.
    Tékus V; Hajna Z; Borbély É; Markovics A; Bagoly T; Szolcsányi J; Thompson V; Kemény Á; Helyes Z; Goebel A
    Pain; 2014 Feb; 155(2):299-308. PubMed ID: 24145209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate cytokine profile in patients with complex regional pain syndrome is normal.
    van de Beek WJT; Remarque EJ; Westendorp RGJ; van Hilten JJ
    Pain; 2001 Apr; 91(3):259-261. PubMed ID: 11275382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant profile in patients with complex regional pain syndrome type I.
    Baykal T; Seferoglu B; Karsan O; Kiziltunc A; Senel K
    Int J Rheum Dis; 2014 Feb; 17(2):156-8. PubMed ID: 24576270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient immune activation without loss of intraepidermal innervation and associated Schwann cells in patients with complex regional pain syndrome.
    Hartmannsberger B; Scriba S; Guidolin C; Becker J; Mehling K; Doppler K; Sommer C; Rittner HL
    J Neuroinflammation; 2024 Jan; 21(1):23. PubMed ID: 38233858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labeled substance P as a neuropeptide reporter substance for enzyme activity.
    Schreiber U; Engl C; Bayer M; König S
    J Pharm Biomed Anal; 2020 Jan; 178():112953. PubMed ID: 31718985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.